{"DataElement":{"publicId":"6183416","version":"1","preferredName":"PRETEXT Staging System Primary Childhood Malignant Liver Tumor Stage","preferredDefinition":"Extent of the primary liver tumor prior to treatment using the PRETEXT staging system.","longName":"PRETEXT_STAGING","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6013461","version":"1","preferredName":"PRETEXT Staging System Primary Neoplasm Childhood Malignant Liver Neoplasm Stage","preferredDefinition":"A staging system designed by the International Childhood Liver Tumor Strategy Group (SIOPEL) for staging and risk stratification of liver tumors. A PRETEXT stage number is based on the number of contiguous liver sections not involved by tumor, corresponding to a rough estimate of the difficulty of the expected surgical procedure. It is used to describe tumor extent before any therapy, thus allowing more effective comparison between studies conducted by different groups._A tumor at the original site of origin._A malignant neoplasm of the liver developed in childhood.  Representative examples include hepatoblastoma, undifferentiated (embryonal) sarcoma, and extrarenal rhabdoid tumor._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6013459v1.0:6013614v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"6013459","version":"1","preferredName":"PRETEXT Staging System\r\n\r\n","preferredDefinition":"A staging system designed by the International Childhood Liver Tumor Strategy Group (SIOPEL) for staging and risk stratification of liver tumors. A PRETEXT stage number is based on the number of contiguous liver sections not involved by tumor, corresponding to a rough estimate of the difficulty of the expected surgical procedure. It is used to describe tumor extent before any therapy, thus allowing more effective comparison between studies conducted by different groups.","longName":"C141133","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PRETEXT Staging System","conceptCode":"C141133","definition":"A staging system designed by the International Childhood Liver Tumor Strategy Group (SIOPEL) for staging and risk stratification of liver tumors. A PRETEXT stage number is based on the number of contiguous liver sections not involved by tumor, corresponding to a rough estimate of the difficulty of the expected surgical procedure. It is used to describe tumor extent before any therapy, thus allowing more effective comparison between studies conducted by different groups.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CDB8564-7D32-375E-E053-F662850ABB4B","latestVersionIndicator":"Yes","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"ONEDATA","dateModified":"2017-10-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6013614","version":"1","preferredName":"Primary Neoplasm Childhood Malignant Liver Neoplasm Stage","preferredDefinition":"A tumor at the original site of origin.:A malignant neoplasm of the liver developed in childhood.  Representative examples include hepatoblastoma, undifferentiated (embryonal) sarcoma, and extrarenal rhabdoid tumor.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C8509:C7708:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Neoplasm","conceptCode":"C8509","definition":"A tumor at the original site of origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Childhood Malignant Liver Neoplasm","conceptCode":"C7708","definition":"A malignant neoplasm that affects the liver and occurs during childhood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CEC8225-165C-5E9D-E053-F662850ADA91","latestVersionIndicator":"Yes","beginDate":"2017-11-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-01","modifiedBy":"ONEDATA","dateModified":"2017-11-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CDB8564-7D40-375E-E053-F662850ABB4B","latestVersionIndicator":"Yes","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"COOPERM","dateModified":"2017-11-06","changeDescription":"Created for request 8.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6013463","version":"1","preferredName":"PRETEXT Staging System Stage","preferredDefinition":"A staging system designed by the International Childhood Liver Tumor Strategy Group (SIOPEL) for staging and risk stratification of liver tumors. A PRETEXT stage number is based on the number of contiguous liver sections not involved by tumor, corresponding to a rough estimate of the difficulty of the expected surgical procedure. It is used to describe tumor extent before any therapy, thus allowing more effective comparison between studies conducted by different groups._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"PRETEXT_STG","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not Applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5682946","version":"1","preferredName":"Not Applicable","longName":"5682946v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9B2B-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-02-20","changeDescription":null,"administrativeNotes":"2023.8.15 Alt VM added per ticket request CADSR0002731. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5CDB9D24-D912-47C4-E053-F662850AAC6C","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"ONEDATA","dateModified":"2017-10-31","deletedIndicator":"No"},{"value":"IV","valueDescription":"PRETEXT Stage 4","ValueMeaning":{"publicId":"6013465","version":"1","preferredName":"PRETEXT Stage 4","longName":"6013465","preferredDefinition":"Hepatoblastoma Pretreatment Extent of Disease System stage in which tumor involves all four quadrants of the liver. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PRETEXT Stage 4","conceptCode":"C28075","definition":"PRETEXT (Hepatoblastoma Pretreatment Extent of Tumor) stage in which the tumor involves all four quadrants of the liver.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CDB9D24-D920-47C4-E053-F662850AAC6C","latestVersionIndicator":"Yes","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5CDB9D24-D939-47C4-E053-F662850AAC6C","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"ONEDATA","dateModified":"2017-10-31","deletedIndicator":"No"},{"value":"III","valueDescription":"PRETEXT Stage 3","ValueMeaning":{"publicId":"6013467","version":"1","preferredName":"PRETEXT Stage 3","longName":"6013467","preferredDefinition":"Hepatoblastoma Pretreatment Extent of Disease System stage in which tumor involves three adjoining quadrants or two nonadjoining quadrants, while one quadrant or two nonadjoining liver quadrants are free of tumor. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PRETEXT Stage 3","conceptCode":"C28074","definition":"PRETEXT (Hepatoblastoma Pretreatment Extent of Tumor) stage in which the tumor involves three adjoining quadrants or two nonadjoining quadrants, while one quadrant or two nonadjoining liver quadrants are free of tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CDB9D24-D946-47C4-E053-F662850AAC6C","latestVersionIndicator":"Yes","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5CDB9D24-D95F-47C4-E053-F662850AAC6C","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"ONEDATA","dateModified":"2017-10-31","deletedIndicator":"No"},{"value":"II","valueDescription":"PRETEXT Stage 2","ValueMeaning":{"publicId":"6013469","version":"1","preferredName":"PRETEXT Stage 2","longName":"6013469","preferredDefinition":"Hepatoblastoma Pretreatment Extent of Disease System stage in which tumor involves two adjoining quadrants, while the other two adjoining liver quadrants are free of tumor. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PRETEXT Stage 2","conceptCode":"C28073","definition":"PRETEXT (Hepatoblastoma Pretreatment Extent of Tumor) stage in which the tumor involves two adjoining quadrants, while the other two adjoining liver quadrants are free of tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CDB9D24-D96C-47C4-E053-F662850AAC6C","latestVersionIndicator":"Yes","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5CDB9D24-D985-47C4-E053-F662850AAC6C","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"ONEDATA","dateModified":"2017-10-31","deletedIndicator":"No"},{"value":"I","valueDescription":"PRETEXT Stage 1","ValueMeaning":{"publicId":"6013471","version":"1","preferredName":"PRETEXT Stage 1","longName":"6013471","preferredDefinition":"Hepatoblastoma Pretreatment Extent of Disease System stage in which tumor involves only one quadrant, while the three adjoining liver quadrants are free of tumor. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PRETEXT Stage 1","conceptCode":"C28072","definition":"PRETEXT (Hepatoblastoma Pretreatment Extent of Tumor) stage in which the tumor involves only one quadrant, while the three adjoining liver quadrants are free of tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CDB9D24-D992-47C4-E053-F662850AAC6C","latestVersionIndicator":"Yes","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5CDB9D24-D9AB-47C4-E053-F662850AAC6C","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"ONEDATA","dateModified":"2017-10-31","deletedIndicator":"No"},{"value":"None","valueDescription":"None","ValueMeaning":{"publicId":"4001711","version":"1","preferredName":"None","longName":"4001711","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED6DCE6B-B411-EF30-E040-BB89AD4369A8","latestVersionIndicator":"Yes","beginDate":"2013-12-13","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-12-13","modifiedBy":"GDEEN","dateModified":"2024-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"673934B3-9D27-3A32-E053-F662850A302A","beginDate":"2018-03-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-12","modifiedBy":"ONEDATA","dateModified":"2018-03-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6013462","version":"1","preferredName":"PRETEXT Staging System\r\n\r\n Stage","preferredDefinition":"A staging system designed by the International Childhood Liver Tumor Strategy Group (SIOPEL) for staging and risk stratification of liver tumors. A PRETEXT stage number is based on the number of contiguous liver sections not involved by tumor, corresponding to a rough estimate of the difficulty of the expected surgical procedure. It is used to describe tumor extent before any therapy, thus allowing more effective comparison between studies conducted by different groups.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C141133:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PRETEXT Staging System","conceptCode":"C141133","definition":"A staging system designed by the International Childhood Liver Tumor Strategy Group (SIOPEL) for staging and risk stratification of liver tumors. A PRETEXT stage number is based on the number of contiguous liver sections not involved by tumor, corresponding to a rough estimate of the difficulty of the expected surgical procedure. It is used to describe tumor extent before any therapy, thus allowing more effective comparison between studies conducted by different groups.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CDB9D24-D8EA-47C4-E053-F662850AAC6C","latestVersionIndicator":"Yes","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"ONEDATA","dateModified":"2017-10-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CDB9D24-D8FB-47C4-E053-F662850AAC6C","latestVersionIndicator":"Yes","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"COOPERM","dateModified":"2018-03-12","changeDescription":"Created for request 8.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"PRETEXT Group:","url":null,"context":"COG"},{"name":"Tumor stage","type":"Preferred Question Text","description":"Tumor stage","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69838E7C-2DFD-3588-E053-F662850A1EF2","latestVersionIndicator":"Yes","beginDate":"2018-04-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-10","modifiedBy":"HARTLEYG","dateModified":"2018-04-10","changeDescription":"Created COG for AHEP1531_04.10.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}